What is Non-Alcoholic Steatohepatitis

Weight management offers patients with liver cirrhosis significant health benefits. This case study describes the treatment of liver cirrhosis through dietary interventions. A 48-year-old male presented at Doctor Soliman Fakeeh Hospital in Saudi Arabia, Jeddah. The patient was suffering from morbid obesity (BMI= 43.76 kg/m2), non-alcoholic steatohepatitis, and chronic hepatitis B viral infection. Sleeve gastrectomy surgery was not possible due to the patient having liver fibrosis (stage 4). Alternatively, he was offered a healthy lifestyle intervention involving advisement regarding dietary habits and the initiation of a regular exercise routine. FibroScan was repeated seven months after the dietary intervention, where it was observed that the liver fibrosis improved from stage 4 to stage 3 post-treatment. Additionally, the patient lost almost 29% of his original body weight. In this case, weight management through following a healthy, balanced diet and increasing physical activity for one year produced remarkable improvement in the patient's liver cirrhosis related to non-alcoholic steatohepatitis.